NON-REFUTING VALUE OF LYMPHOTROPIC THERAPY FOR THE PREVENTION OF INTESTINAL COMPLICATIONS IN THE POSTOPERATIVE PERIOD AT ULCERATIVE COLITIS
https://doi.org/10.17238/issn2072-3180.2020.3.22-26
Abstract
This article examines the definition of lymph circulation in the intestinal mesentery system in normal conditions and in the UC model, as well as the management and treatment of patients with ulcerative colitis using lymphotropic therapy in the postoperative period. The aim of this work is to study and evaluate the non-refuting value of lymphotropic therapy in patients in the complex treatment of UC in the postoperative period.
Material and methods. In several experiments on animals - such as dogs, we have created a model of ulcerative colitis, and at the same time, before and after the creation of the model, we studied the lymph circulation in the intestinal mesentery. Based on the results of experimental studies, lymphotropic therapy was applied in clinical conditions in the complex treatment of ulcerative colitis in the postoperative period in 54 patients. To compare the results of lymphatic therapy, a control group of 43 patients was created who received conventional conventional treatment in the postoperative period.
Results. When using lymphotropic therapy in the complex treatment of ulcerative colitis, the number of intestinal complications in the postoperative period is significantly reduced and the patient's stay in the hospital is reduced.
About the Authors
Yu. S. EgamovUzbekistan
Egamov Yuldashali Sulaimanovich — Doctor of Medical Sciences, Professor
170100, Andizhan region, Andizhan, street Atarbekova, 1
A. E. Ruziyev
Uzbekistan
Ruziyev Akhtam Ergashovich — applicant
2001181, Bukhara, A. Navoi str., 1
S. A. Khaidarov
Russian Federation
Khaidarov Sarvar Adkhamovich — doctoral student
170100, Andizhan region, Andizhan, street Atarbekova, 1
References
1. Adler G. Bolezn’ Krona i yazvennyj kolit [Crohn’s disease and ulcerative colitis]. M.: GEOTAR- Mediа, 2001, 527 p. (In Russ.).
2. Vorobiev G.I., Khalif I.L. Nespecificheskie vospalitel’nye zabolevaniya kishechnika [Nonspecific inflammatory bowel diseases]. M: Miklos, 2008. 400 p. (In Russ.).
3. Grigorieva G.A., Meshalkina N.Yu. Bolezn’ Krona [Crohn’s disease]. M.: Medicine, 2007, 84 p. (In Russ.).
4. Asanin Yu.Yu. et al. Indeks Maseevicha: Novyj podhod k ocenke kliniko-endoskopicheskoj aktivnosti yazvennogo kolita [Index Maseevich: A new approach to assessing the clinical and endoscopic activity of ulcerative colitis]. Gastroenterology, 2004, 1, pp. 14−16 (In Russ.).
5. Poluektova E.A., Lyashenko O.S., Korolev A.V. Mekhanizmy, obespechivayushchie vzaimodejstvie bakterial’nyh kletok s organizmom hozyaina i ih narushenie u pacientov s vospalitel’nymi zabolevaniyami kishechnika [Mechanisms that ensure the interaction of bacterial cells with the host organism and their disruption in patients with inflammatory bowel diseases]. Russian journal of gastroenterology, hepatology, coloproctology, 2014, 5, pp. 42−53 (In Russ.).
6. Sekacheva M.I. Modern aspects of the treatment of ulcerative colitis: the results of evidence-based medicine. Consilium Medicum [Electronic resource], 2003, Vol. 5, 10. Access mode (http://www.consiliumedicum.com/media/consilium/03_10c/18shtmi) (In Russ.).
7. Suvorova G.N., Myakisheva Yu.V., Katorkin S.E., Andreev PS, Davydova O.E., Lyamin A.V., Kruglov E.E., Sukhachev P.A. Gistologicheskaya kartina i mikrobnyj pejzazh pri yazvennom kolite. [Histological picture and microbial landscape in ulcerative colitis]. Bulletin of new medical Technologies, 2018, 4, pp. 170−175 (In Russ.).
8. Khalif I.L. Hirurgicheskoe lechenie i biologicheskaya terapiya pri yazvennom kolite [Surgical treatment and biological therapy for ulcerative colitis]. Russian medical journal, 2013, 31, p. 1632 (In Russ.).
9. Khalif I.L. Vospalitel’nye zabolevaniya kishechnika (nespecificheskij yazvennyj kolit i bolezn’ Krona): klinika, diagnostika i lechenie [Inflammatory bowel diseases (ulcerative colitis and Crohn’s disease): clinical presentation, diagnosis and treatment]. M.: Miklosh, 2008, 256 p. (In Russ.).
10. Khalif I.L. Lechebnaya taktika pri yazvennom kolite [Therapeutic tactics for ulcerative colitis]. Russian Journal of Gastroenterology, Hepatology and Colopractology, 2006, 3, pp. 58−61 (In Russ.).
11. Egamov Yu.S., Ruziev A.E., Khaidarov S.A. Endomezenterial’naya limfotropnaya terapiya kak metod, preduprezhdayushchij oslozhneniya v kompleksnom lechenii nespecificheskogo yazvennogo kolita v posleoperacionnom periode [Endomesenteric lymphotropic therapy as a method of preventing complications in the complex treatment of ulcerative colitis in the postoperative period]. Journal of New Day in Medicine, 2019, 3. pp. 299−303 (In Russ.).
12. Dorofeev A.É., Shvets O.V. Epidemiology and risk factors of inflammatory bowel diseases. LikSprava, 2014, (11), pp. 22−29.
13. Langan R.C., Gotsch P.B., Krafczyk M.A. et al. Ulcerative colitis: diagnosis and treatment. Am. Fam. Physician, 2007, 76 (9), pp. 1323−1330.
14. Marinov V. Investigation of two models of trinitrobenzenesulfonicacidnduced colitis in rats. Trakia Journal of Sciences, 2015, 13 (Suppl. 2), pp. 49−54.
15. Szalai Z. et al. Novel features of tea rat model of inflammatory bowel disease based on 2,4,6-trinitrobenzenesulfonic acid-induced acute colitis. Acta Biologica Szegediensis, 2014, 58 (2), pp. 127−132.
Review
For citations:
Egamov Yu.S., Ruziyev A.E., Khaidarov S.A. NON-REFUTING VALUE OF LYMPHOTROPIC THERAPY FOR THE PREVENTION OF INTESTINAL COMPLICATIONS IN THE POSTOPERATIVE PERIOD AT ULCERATIVE COLITIS. Moscow Surgical Journal. 2020;(3):22-26. (In Russ.) https://doi.org/10.17238/issn2072-3180.2020.3.22-26